Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans
Clinical trial NCT02922166 · UNKNOWN
Trial details
- NCT number
- NCT02922166
- Sponsor
- Azevan Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-03
- Primary completion
- 2019-05-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.